Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
editorial
. 2009 Jul 13;68(3):106–107. doi: 10.1016/S1726-4901(09)70229-1

Clinical Findings, Treatment and Prognosis in Patients with Severe Acute Respiratory Syndrome (SARS)

Shan-Chwen Chang 1,*
PMCID: PMC7130064  PMID: 15813242

The content is available as a PDF (121.3 KB).

References

  • 1.Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
  • 2.Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. doi: 10.1056/NEJMoa030747. [DOI] [PubMed] [Google Scholar]
  • 3.Peiris JS, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLH, Law KI. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi: 10.1016/S0140-6736(03)13412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. doi: 10.1056/NEJMoa030685. [DOI] [PubMed] [Google Scholar]
  • 5.Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  • 6.Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, Chang SC. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10:818–824. doi: 10.3201/eid1005.030640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Liu CY, Huang LJ, Lai CH, Chen HP, Chen TL, Fung CP, Liu CY. Clinical characteristics, management and prognostic factors in patients with probable severe acute respiratory syndrome (SARS) in a SARS center in Taiwan. J Chin Med Assoc. 2005;68:110–117. doi: 10.1016/S1726-4901(09)70231-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045–2046. doi: 10.1016/S0140-6736(03)13615-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wang WK, Chen SY, Liu IJ, Kao CL, Chen HL, Chiang PL, Wang JT. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004;39:1071–1075. doi: 10.1086/423808. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Chinese Medical Association are provided here courtesy of Elsevier

RESOURCES